Galibier Capital Management’s GSK GSK Stock Holding History

Galibier Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-165,090	Closed	-$8.99M	–	43
2022 Q1	$8.99M	Sell	165,090 -41,280	-20%	-$2.24M	1.21%	15
2021 Q4	$11.4M	Sell	206,370 -203,882	-50%	-$10.6M	1.63%	15
2021 Q3	$19.6M	Hold	410,252	–	–	2.68%	13
2021 Q2	$20.4M	Sell	410,252 -50,341	-11%	-$2.42M	2.75%	14
2021 Q1	$20.5M	Hold	460,593	–	–	3.09%	12
2020 Q4	$21.2M	Buy	460,593 +100,000	+28%	+$4.59M	3.66%	12
2020 Q3	$17M	Buy	+360,593	New	+$18.1M	3.99%	10

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Galibier Capital Management's GSK Position: Q2 2022 in Review

Galibier Capital Management sold out of GSK (GSK) in Q2 2022, closing a stake of 165,090 shares — an estimated $8.99M sold.

Galibier Capital Management first reported a position in GSK in Q3 2020 and held it in 7 quarters. The position peaked at $21.2M in Q4 2020. 900 funds tracked by Wall St. Rank hold GSK as of Q2 2022.

Galibier Capital Management reported no remaining GSK position as of Q2 2022 after selling out during the quarter.
Galibier Capital Management sold 165,090 GSK shares in Q2 2022, an estimated $8.99M.
Galibier Capital Management first reported a position in GSK in Q3 2020 and held it in 7 quarters.
Galibier Capital Management's GSK position peaked at $21.2M in Q4 2020.
900 funds tracked by Wall St. Rank held GSK as of Q2 2022.

Based on Galibier Capital Management's 13F filing for Q2 2022, filed 15 Jul 2022.